Validation of the DNA Damage Immune Response Signature in Patients With Triple-Negative Breast Cancer From the SWOG 9313c Trial MRD was assessed after induction treatment and at different times during ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback